News

UGA partners presented the BIOCAPAN project at the French Annual Diabetes Congress: a poster and a symposium talk!

The BIOactive implantable CApsule for PANcreatic islets immunosuppression-free therapy consortium was established in 2014 and was awarded a €8,000,000 grant by the European Commission under the auspices of the HORIZON2020 research program. The project was launched in June 2015 and is currently completing its third out of four years of funded research. The project will end on May 31st 2019.

The meeting in Oslo was dedicated to discuss the projects current progress and the planning of the next steps.

Biocapan partners met Paul Ehrlich Institute in Langen/Frankfurt for scientific advice in respect of the final preclinical studies and the classification of the BIOCAPAN capsule.

Biocapan consortium validated the composition of the BIOCAPAN capsule

The 4th consortium meeting took place on 20-21 February 2017 in Brussels, Belgium. The BIOCAPAN partners showed their main achievements in the last six months and discussed best strategies for setting up the upcoming work.

The BIOCAPAN consortium has met a third time on 6th and 7th June 2016 in Berlin, Germany. Besides the presentation of results of ongoing work and discussions of current “hot topics” in the project, the planning of further steps was an important part.

Coordinator Florence Rivera was interviewed by EPM Magazine on the project. See here the article.

Partner NIT has translated and spread information on BIOCAPAN also in the Spanish-speaking scientific community and beyond; the links below show two articles.

An article with the title “Leti & Eight Partners in BIOCAPAN Project Working On Diabetes Treatment to Replace Injections”,. was published by “Drug Development & Delivery”, which is a print, online and event provider with a circulation of ca. 20.000 readers, from which 5.000 are online only.

The BIOCAPAN press release was translated into German and published by the partner Charité with the title “Diabetestherapie ohne Insulin - Charité-Wissenschaftler forschen an neuer Behandlungsform.” The information was taken up by an independent German diabetes news site, which refers to the project.

The online magazine ‘Evaluation Engineering’ published an article with the title: “BIOCAPAN working on diabetes treatment that replaces insulin injections”. The magazine has 51.876 print/online subscribers (2016).